Zenith Epigenetics Stock

Zenith Epigenetics Corp. is a research and development biotechnology company focused on new and innovative drugs by leveraging its

Sign up today and learn more about Zenith Epigenetics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Zenith Epigenetics Stock

Zenith Epigenetics Corp. is a research and development biotechnology company focused on new and innovative drugs by leveraging its proprietary epigenetics platform. The company's epigenetic drug discovery platform functions by inhibiting BET bromodomains, having the potential to impact multiple diseases including autoimmune and oncology.

Funding History

March 2014$8.0M
July 2014$4.6M
May 2015$4.0M

Management

Chief Business Officer

Sanjay Lakhotia

President and CEO

Donald McCaffrey

President and Chief Executive Officer

Julie Cherrington

Chief Scientific Officer

Norman Wong

Vice President of Drug Discovery and Exploratory Development

Michael Yakes

Senior Vice President of Operations

Henrik Hansen

CFO

Brad Cann

Senior Director of Pharmacology

Ravi Jahagirdar

Chief Medical Officer

Joy Zhu

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo